Rachael M. Zemek

Nedlands, WA, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models.

Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models.

Journal: Scientific reports
Published: November 03, 2025

Genital herpes shedding episodes associate with alterations in the spatial organization and activation of mucosal immune cells.

Genital herpes shedding episodes associate with alterations in the spatial organization and activation of mucosal immune cells.

Journal: bioRxiv : the preprint server for biology
Published: July 16, 2025

Genital herpes shedding episodes associate with altered spatial organization and activation of mucosal immune cells.

Genital herpes shedding episodes associate with altered spatial organization and activation of mucosal immune cells.

Journal: JCI insight
Published: July 01, 2025

Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockade.

Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockade.

Journal: Oncoimmunology
Published: August 27, 2024

Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes.

Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes.

Journal: Oncoimmunology
Published: April 30, 2024

Exploiting temporal aspects of cancer immunotherapy.

Exploiting temporal aspects of cancer immunotherapy.

Journal: Nature reviews. Cancer
Published: April 25, 2024

Protocol for delivery of intraoperative immunotherapy to mice by surgical debulking of subcutaneous tumors.

Protocol for delivery of intraoperative immunotherapy to mice by surgical debulking of subcutaneous tumors.

Journal: STAR protocols
Published: November 16, 2023

Celebrating 100 years of Immunology & Cell Biology - a special focus on the field of tumor immunology in Australia.

Celebrating 100 years of Immunology & Cell Biology - a special focus on the field of tumor immunology in Australia.

Journal: Immunology and cell biology
Published: September 11, 2023

Tretinoin improves the anti-cancer response to cyclophosphamide, in a model-selective manner.

Tretinoin improves the anti-cancer response to cyclophosphamide, in a model-selective manner.

Journal: BMC cancer
Published: August 18, 2023

Time-course RNAseq data of murine AB1 mesothelioma and Renca renal cancer following immune checkpoint therapy.

Time-course RNAseq data of murine AB1 mesothelioma and Renca renal cancer following immune checkpoint therapy.

Journal: Scientific data
Published: June 20, 2023

A surgically optimized intraoperative poly(I:C)-releasing hydrogel prevents cancer recurrence.

A surgically optimized intraoperative poly(I:C)-releasing hydrogel prevents cancer recurrence.

Journal: Cell reports. Medicine
Published: December 14, 2022

Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma.

Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma.

Journal: PloS one
Published: September 11, 2022
Showing 1-12 of 22

Last Updated: 09/26/2026